CONCEPT: A 1-Year Comparison Of A Stable Dose Of SERETIDE® Inhaler With An Adjustable Maintenance Dose Of SYMBICORT® Inhaler. SERETIDE® Inhaler is a Trademark of GSK Group of Companies. SYMBICORT® Inhaler is a Trademark of Astra Zeneca.
Clinical trial NCT00479739 · COMPLETED
Trial details
- NCT number
- NCT00479739
- Sponsor
- GlaxoSmithKline
- Status
- COMPLETED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2002-11-01
- Primary completion
- 2004-07-01
- Enrollment
- 700
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.